Chen K W, Anderson J P, Mueller T. "一种的合成方法" [P]. US Patent, US 11080999 B2, 2022-08-17.
发明人唐晓军,李文辉,刘建华. "Method for the Synthesis of 3-(1H-Imidazol-2-yl)-1,2,4,5-tetrazine" [P]. 中国发明专利, 专利号 CN 108430277 A, 授权公告日 2018-10-28.
发明人郑宇鹏,郭海燕,王建平. "A Process for Preparing High-Purity 3-(1H-Imidazol-2-yl)-1,2,4,5-tetrazine" [P]. 中国发明专利, 专利号 CN 109596949 A, 授权公告日 2016-06-15.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Molecules, 2014, 2033, 2722-2737.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Rapid Commun. Mass Spectrom., 2011, 739, 6264-6277.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of 3-(1H-Imidazol-2-yl)-1,2,4,5-tetrazine Using HRMS and NMR". Anal. Methods, 2021, 1282, (10), 4588-4616.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2023, 1262, 9915-9924.